Subscribe for weekly videos: http://www.YouTube.com/channel/UCpfFuYBEvhvmJWSo_9vWY6A?sub_confirmation=1 Watch this video and more in “Men’s Health Best Worko…
Video Rating: 4 / 5
Alexandria, Virginia (PRWEB) September 15, 2014
The National Military Family Association (NMFA), a nonprofit that works to strengthen and protect military families, and UnitedHealth Group, a diversified health and well-being company, announced today that they are hosting an event on September 16th titled Growing Our Own Meeting the Behavioral Health Needs of Military Families.
This program will examine behavioral health challenges faced by military families. Speakers will also highlight innovative solutions to improve access to behavioral health care and meet the increasing demand for qualified health providers. The program will feature representatives from NMFA, UnitedHealth Group, and RAND.
Topics that will be covered during this discussion include:
New York, NY (PRWEB) September 13, 2014
The Class of 2015, the 9th Class of ABFE Fellows, is an exciting group of philanthropic professionals. The six men and four women have vast experience across a range of issue areas including youth development, health, education and advocacy. The class is also geographically diverse, with three members from the South, three from the West, one from the Mid-West and three from the NY-DC corridor.
The Connecting Leaders Fellowship Program (CLFP) is a year-long, comprehensive leadership and professional development experience. Fellows will participate in leadership and personality assessments, receive 10 hours of individual executive coaching, and participate in monthly conference calls with their cohort. Fellows will also conduct a personalized project of their choosing.
The CLFP year officially kicks off with a four-day, intensive Leadership Summit, which takes place November 3-7, 2014 in Birmingham, Alabama.
ABFE launched the CLFP in 2005 to improve retention and career advancement for Black professionals in the field of philanthropy. Its track record is impressive. Over 80% of alumni are still in the field of philanthropy and CLFP alumni respondents to a 2012 survey credited the Fellowship in the following positive ways: Getting a promotion–12%; gaining more responsibility in current role–55%; Moving to a new organization in philanthropy–37%; Getting a promotion in a new organization–45%. In 2013-2014, three alumni were named CEO of their foundations.
ABFE’s first Leadership Summit in the South is going to Birmingham at the request and considerable planning of Lyord Watson ’12. Lyord is a founding member of the Birmingham Change Fund, a board member of the Community Investment Network, and he was recently elected to the Birmingham Board of Education. With a passion for encouraging a more participatory and strategic form of philanthropy in Birmingham, Lyord felt that the Leadership Summit was a natural catalyst to start a new conversation. Lyord regularly speaks in the language of ABFE Responsive Philanthropy in Black Communities framework and he remembers how rich his discussions were with people in Newark, NJ during his own Summit. “Bringing a talented group of experts and leaders who are passionate about change to Birmingham will be a wonderful gift for my city.”
A selection committee comprised of CLFP Alumni and ABFE members reviewed the thirty applications and made final recommendations of the current class. Fellows were chosen based upon a set of criteria covering their experience in philanthropy, their goals for the future, and their interest and passion for making systemic change in Black communities.
For a complete list of ABFEs 2014-2015 Connecting Leaders Fellows, see page two or visit abfe.org.
According to the National Institutes of Health, approximately 5% of 40-year-old men and between 15% and 25% of 65-year-old men experience erectile dysfunctio…
Denver, CO (PRWEB) September 11, 2014
Three internationally recognized addiction and mental health experts will speak at conferences this fall that are co-hosted by Promises Treatment Centers and produced by the Ben Franklin Institute:
Wickenburg, Arizona (PRWEB) September 09, 2014
The Meadows trauma and addiction treatment center announced Chief of Psychiatry, Jon Caldwell, DO, PhD, will be a featured presenter at Gender Matters, Men Matter, a groundbreaking conference presented by Center for Dependency, Addiction and Rehabilitation (CeDAR) at the University of Colorado Hospital. The conference will focus on Addiction, Men, Trauma, and How to Evolve in Our Treatment for Men and will be held October 10-12, 2014, at the Omni Hotel and Resort in Broomfield, Colo.
This event is the first national conference to focus on the needs of men in treatment. Topics to be addressed on the conference agenda will include the role of trauma in mens recovery, the healing of generational wounds, passivity and aggression in men, and many other issues in men’s recovery. Also on the conference schedule will be a panel discussion conveying a framework for the development of trauma-informed care for men.
Dr. Caldwell will present Meeting Toxic Shame with Tender-Hearted Presence: Exploring Links between Gender, Shame, and Mindful Self-Compassion. In his presentation, Dr. Caldwell will explore differences between women and men in the experience of shame and the utilization of compassionate presence. In addition, he will offer practical tools for helping people in recovery to meet toxic shame with greater mindfulness and self-compassion. Dr. Caldwell is known for his humorous anecdotes, compelling research findings, and experiential exercises.
The Meadows prides itself in offering cutting-edge, evidence-based trauma and addiction treatment. Im looking forward to sharing my research and experience with this group, Dr. Caldwell said.
In addition to informative presentations by national speakers, this conference will have a heavy experiential component with numerous opportunities for fellowship and networking that include a comedy performance and a golf outing. The conference will also feature ArtSpeaking Our Truth a display of creative writings, pictures, poetry, sculpture, and images that express an understanding of being male, addicted, and having a history of trauma.
For information regarding the conference, please contact Ben.Cort@uchealth.org or call (720) 848-2996. To register, visit http://www.CeDARColorado.org. Registration fee includes 17.5 NAADAC continuing education hours, breakfast and lunch all three days of the conference.
The Meadows is an industry leader in treating trauma and addiction through its inpatient and workshop programs. To learn more about The Meadows work with trauma and addiction contact an intake coordinator at (866) 856-1279 or visit http://www.themeadows.com.
For over 35 years, The Meadows has been a leading trauma and addiction treatment center. In that time, they have helped more than 20,000 patients in their inpatient center and 25,000 attendees in national workshops. The Meadows world-class team of Senior Fellows, Psychiatrists, Therapists and Counselors treat the symptoms of addiction and the underlying issues that cause lifelong patterns of self-destructive behavior. The Meadows, with 24-hour nursing and on-site physicians and psychiatrists, is a behavioral health inpatient facility that is licensed by the Arizona Department of Health Services and accredited by The Joint Commission.
San Diego, CA (PRWEB) May 22, 2014
AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for MV5 Days.
The FDA notified consumers on May 16, not to purchase or use MV5 Days because it contains sildenafil. MV5 Days is promoted as a product for sexual enhancement.
Sildenafil is the active ingredient in Viagra, the FDA approved prescription drug used to treat erectile dysfunction. This ingredient may interact with nitrates found in certain drugs used to treat heart disease, high blood pressure and diabetes and can lower blood pressure to dangerous levels.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds we are determined to keep an eye on FDA announcements concerning MV5 Days and inform the public. For that reason”, he continues, “our focus should squarely fall on investigating these safety alerts and getting the word out.
As the FDA advises Do not purchase or use MV5 Days.
AttorneyOne.com has further information on MV5 Days at the website including latest major drug and medical products law news.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11871885.htm
New York, N.Y. (PRWEB) June 16, 2014
The findings of an in-depth investigation published in The New York World on May 30, talks about the serious dangers posed by sidewalk sheds in New York City. According to the report, sidewalk sheds are an increasingly common sight in the city where the Department of Buildings requires them at any construction, remodeling or demolition site.
However, what The New York World’s investigation recently found is that the special Scaffold Safety Team formed in 2007 under Mayor Michael Bloomberg has thinned out from 17 field inspectors in 2008 to nine in 2013. This reduction in enforcement staff, the report says, has caused the number of violations issued for faulty sheds to drop from 855 in 2009 to 337 in 2013.
Also, since January 2011, 39 pedestrians and construction workers have suffered injuries involving sidewalk sheds. The article cites examples of incidents where a victim was hit on the head by debris while walking near a sidewalk shed in the East Village as well as that of a child who suffered an electrical shock after she touched a sidewalk shed carrying live electrical voltage in Red Hook, Brooklyn. There are currently more than 10,000 sidewalk sheds in New York City, according to the article.
Sidewalk sheds that are improperly constructed or maintained can pose serious hazards to pedestrians and bystanders, said New York personal injury lawyer Kenneth A. Wilhelm. “A sidewalk shed is a structure erected over a sidewalk to protect pedestrians from objects that may fall from a nearby construction site. When these structures are not properly built, pedestrians could get hit by falling debris or equipment and suffer serious head injuries and other traumatic injuries.”
The city as well as the contractors and construction companies that put together these sheds have a duty to safeguard the public, he said. “I certainly hope that the city steps up enforcement of how these sheds are constructed and maintained. It is unfortunate that the staffing levels of the Scaffold Safety Team created specifically to monitor these sheds have come down. It is crucial at this point for the city to step up enforcement and protect New Yorkers from serious injuries caused by faulty sidewalk sheds.”
About the Law Offices of Kenneth A. Wilhelm
The Law Offices of Kenneth A. Wilhelm is a personal injury litigation firm with an unwavering dedication to its clients. With more than 42 years of experience, our firm strives to obtain the best compensation for those who have been injured or those who have lost a loved one due to an accident or by someone else’s negligence. We handle cases dealing with personal injury, medical malpractice, wrongful death, train accidents, workers’ compensation, dental malpractice, motor vehicle accidents, pedestrian accidents, rape, paralysis, comas, seizures, false arrest, lead poisoning, trips and slips and falls, falls on sidewalks or stairs, elevator accidents, construction accidents, building collapses and explosions, Erb’s palsy, cerebral palsy, brain damage, blindness, hearing loss, dog bite cases, fire and smoke inhalation accidents, bicycle accidents, falls from windows or scaffolds, food poisoning injuries, carbon monoxide accidents, and many other types of accidents and injuries.
Please contact our New York personal injury attorneys TOLL FREE 24 hours a day, 7 days a week at 1-800-WORK-4-YOU (1-800-967-5496). WE CAN EVEN COME TO YOU. There is no attorneys’ fee unless we recover money for you. We can also help with personal injury cases in New Jersey, Connecticut, Pennsylvania, or Florida. If you have been seriously injured in any of the 50 U.S. states, please call us and we will try to help you with your case.
Other TOLL FREE phone numbers for us are:
1-800-RADIO-LAW, 1-888-WYPADEK, OR 1-800-LAS-LEYES
The Law Offices of Kenneth A. Wilhelm
(PRWEB) May 24, 2014
#1 Leader in Forskolin Private Label Wholesale is Vox Private Label Supplements
Industry leading private label supplement manufacturer, Vox Private Label Supplements, announces production increases for the supplement Forskolin. Forskolin has been in in-stock for over a year at Vox Private Label Supplements, and is now leading to increased sales amongst the supplement industry. Because Vox Private Label Supplements has had this product in-stock, production order were done immediately and will be in-stock the week of May 26th.
Recently aired on a popular daytime health and wellness television program by Americas Favorite Doctor, Forskolin supplements have had accelerated increases in sales and production outputs.
ForskolinA chemical substance found in the root of the native plant of India called Coleus Forskohlii. Used for centuries to treat heart problems and blood pressure issues, It has also been successfully used to help with allergies, eczema, psoriasis and painful menstrual cramps. In some cases it has been used to even treat erectile dysfunction. Most commonly it is known for being touted by Americas favorite Dr. as a weight loss supplement though. It has been found to activate the fat burning enzyme adenylate cyclase which triggers the amount of AMP in Cells. cAMP basically tells cells to burn stored fat for energy, therefore causing fat to burn from the inside-out.
Points on Forskolin:
Forskolin is Natural
Forskolin Can Break Down Excess Fat
Forskolin Can Release Fatty Acids
A 2005 study (http://www.nature.com/oby/journal/v13/n8/full/oby2005162a…) by Department of Health, Sport and Exercise Sciences, Applied Physiology Laboratory at the University of Kansas: which observed the effect of Forskolin on obese and overweight men showed positive weight loss results in participants.
About Vox Private Label Supplements:
Vox Nutrition is a private label supplement manufacturer that specializes in private labeling. We have had experience in the health and fitness industry for over a decade, since 2002. Specializing in nutritional supplement products, we not only have high quality products, but have the fastest turnaround time on the market. Our average turnaround time is 72 hours, a great benefit for your company. A further benefit of using our company is the ability of purchasing at lower minimums, giving you access to supplements, weight loss and vitamin products without acquiring excessive inventory. Utilizing our company as your private label manufacturer gives your business access to product expertise and knowledge, along with our production capacity. We are a FDA Registered facility that follows the GMP guidelines to ensure the safest and most accurate product for you and your customers
As the leading contract supplement manufacturer of weight loss, wellness, and sports supplements, we are always on track with todays industry changes and trends.
See our Promotional Video on Forskolin at https://www.youtube.com/watch?v=yvXgdDNCGAU.
For additional information on Forskolin and other products, as well as custom formulation, fulfillment (Ship Central) and graphic design labeling services, please contact us at 800-795-7161 or sales(at)voxnutrition(dot)com.
To learn more about Vox or Forskolin, please contact any sales account rep at:
12411 S 265 W Suite C
Draper, Utah 84020
Office: (800) 795-7161
Rochester, NY (PRWEB) August 12, 2014
Infected with the genital herpes virus (HSV-2)? The CBCD recommends taking Novirin or Gene-Eden-VIR. – Greg Bennett, CBCD
Women with an asymptomatic genital herpes infection (an infection with no symptoms) can unknowingly pass HSV to their unborn children in the womb. HSV-2 can also infect babies if mothers give birth vaginally. However, most mothers with asymptomatic genital herpes dont even know they are infected. WebMD says that The vast majority — between 75% and 90% – don’t know they are infected because they don’t get, or don’t notice, herpes sores on their genitals. (See WebMD, published April 12, 2011) (2) Moreover, nearly all the time, these people had no obvious sign of herpes infection while they were actively shedding virus. (2) The CBCD urges expectant mothers to get tested for genital herpes (HSV-2) whether they have symptoms or not. This is important since, as Dr. Michelle Williams wrote, Genital HSV infection occurring during early pregnancy is associated with an increased risk of spontaneous abortion, intrauterine growth restriction, preterm labor and congenital herpes. (See Patient.co.uk, from October 16, 2012) (3) Dr. Williams works for the Hurley Group Primary Care Centres in London. In addition to getting tested for genital herpes, the CBCD recommends that infected women take Novirin or Gene-Eden-VIR to help the immune system target the latent HSV-2. However, they should stop taking it before getting pregnant, and start taking again after delivering the baby.
Click to learn more about genital herpes symptoms.
The Center for the Biology of Chronic Disease (CBCD) recommends that women who are planning a pregnancy, and who suspect they may have a genital herpes (HSV-2) infection, take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Novirin and Gene-Eden-VIR formula is effective against HSV, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, individuals infected with HSV (and other viruses) reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR. (4) The study authors also wrote that, We observed a statistically significant decrease in the severity, duration, and frequency of symptoms. (4)
Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
The CBCD believes women should not take the possibility of an asymptomatic genital herpes infection lightly. This is because the number of women with a genital herpes infection is rising. Dr. Kumar wrote in a study that Genital herpes, which was considered to be a minor sexually transmitted disease (STD) in the past in developing countries, is rapidly increasing. (See the Journal of Dermatology, from February 2002) (5) Dr. Kumar is from the Department of Dermatology at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. Another reason for women to be concerned is the fact that HSV-2 infection is more common in women (approximately one out of four women) than in men (almost one out of five). (See MedicineNet.com, Last reviewed July 2004) (6).
What treatments are available for herpes infections?
Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day. (See Pharmacology & Pharmacy from September 2013) (4). There are also natural antiviral products that studies show to be safe and effective in reducing herpes symptoms. Two of these products are Novirin and Gene-Eden-VIR.
We recommend that women carrying the HSV virus take Novirin or Gene-Eden-VIR. Greg Bennett, CBCD
Individuals interested in viewing published studies on the formula of Gene-Eden-VIR and Novirin can go here, http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101 and http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.U-iXtOOSz90.
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Van Der Pol B. Sexually transmitted infections in women. Scand J Clin Lab Invest Suppl. 2014;74(244):68-74.
(2) DeNoon, D. WebMD.com – Genital Herpes Health Center – Genital Herpes’ Silent Spread. Published April 12, 2011.
(3) Patient.co.uk – Genital Herpes in Pregnancy. Last Reviewed on October 16, 2012.
(4) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013. http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(5) Kumar B1, Sahoo B, Gupta S, Jain R. Rising incidence of genital herpes over two decades in a sexually transmitted disease clinic in north India. J Dermatol. 2002 Feb;29(2):74-8.
(6) MedicineNet.com – Genital Herpes – On the Rise! Last reviewed in July 2004